Heghine Khachatryan on WFH’s Call to Advance Health Equity for People with Bleeding Disorders
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, reposted from
Salome Mekhuzla and WFH on LinkedIn:
”I strongly welcome and support the World Federation of Hemophilia’s formal letter to the WHO Director-General, calling for global action to advance health equity for people living with hemophilia and other bleeding disorders.
This initiative is especially timely as the draft resolution will be discussed at the 158th Session of the WHO Executive Board (EB158).
It reflects a crucial collective effort to ensure that bleeding disorders are recognized as a global public health priority and that patients worldwide have equitable access to diagnosis, care, and treatment.
As a hematologist and an active contributor to this global process, I am proud to see the strong and unified voice of the international bleeding disorders community being represented at the highest level of global health governance.
Looking forward to the discussion at EB158 and to continued collaboration toward sustainable, equitable solutions for patients globally.”
Quoting Salome Mekhuzla‘s post:
”Read the WFH open letter to the WHO Director-General in support for the draft resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders here!
This landmark resolution is scheduled to be discussed at the 158th session of the WHO Executive Board next Monday, February 2nd, tentatively in the afternoon central european time, so morning hours for those in EST time zone.
The WFH will be participating at this session and we will deliver a statement to represent our global community’s voice in front of WHO leadership and national governments!
Keep an eye on our social media posts on Monday, as we will share a web link for anyone interested to follow this discussion live.”
Quoting World Federation of Hemophilia (WFH)‘s post:
”The World Federation of Hemophilia has formally presented a letter to the WHO Director-General, urging support for a World Health Assembly resolution on Global Action to Advance
Health Equity for People with Hemophilia and Other Bleeding Disorders.
This global call highlights the ongoing gaps in diagnosis, treatment, and care, and the urgent need for coordinated action so access to care no longer depends on where someone lives.
The draft resolution is tabled for discussion at the 158th Session of the WHO Executive Board (EB158) in Geneva during February 2 to 7, 2026.
The WFH commands leadership of WHO Member States in driving this resolution adoption process: Armenia as lead Member States, and co-sponsored by Bosnia and Herzegovina, Egypt, Georgia, Iraq, Latvia, Malta, Morocco, Nepal, Paraguay, Spain, Sri Lanka and Togo.
The WFH also thanks all member and partner organizations who have joined the WFH’s Global Call for Health Equity for Bleeding Disorders in support of the landmark resolution.
Read the letter.”
Stay updated with Hemostasis Today.
-
Mar 16, 2026, 07:26James Crowley, Professor of Medicine emeritus at Brown University, posted on LinkedIn:
-
Mar 15, 2026, 15:55Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 2
-
Mar 15, 2026, 14:09Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib – The Clinical Tightrope
-
Mar 15, 2026, 14:02Denise M: Precision Hemostasis in Patient Blood Management
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes
-
Mar 15, 2026, 13:45Tareq Abadl: Has Anyone Here Ever Taken an ALP Test Before?
-
Mar 14, 2026, 21:30Ayman Elbadawi: Why Does Stent Thrombosis Still Occur? Insights from the NCDR Data
-
Mar 14, 2026, 20:03Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency